Actis Generics Private Limited

Actis Generics Private Limited - pharma in Vijayawada, Andhra Pradesh, India. FY 2026 financials & compliance.
CIN U24230AP2012PTC080702 Incorporated 03 May 2012 ROC Vijayawada HQ Vijayawada, Andhra Pradesh, India
Active Private Limited Company pharma MSME · Medium
Revenue · FY 2024
₹70.08 Cr
▲ 7% YoY
Net profit · FY 2024
₹6.54 Cr
Net margin 9.3%
EBITDA · FY 2024
₹14.59 Cr
EBITDA margin 20.8%
Authorised capital
₹7.55 Cr
Registered with MCA
Paid-up capital
₹7.45 Cr
Issued & subscribed
Open charges
₹32.26 Cr
Satisfied ₹38.88 Cr
Company age
14 yrs
Est. 2012
Employees · EPFO
142
Provident fund records

About Actis Generics Private Limited

Data last updated:

Actis Generics Private Limited is a private limited company based in Vijayawada, Andhra Pradesh, India. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 03 May 2012 and has been in existence for over 14 years.

The company is registered with the Registrar of Companies (ROC), Vijayawada, under CIN U24230AP2012PTC080702. Its GSTIN is 37AAKCA5168N1Z1 (Andhra Pradesh).

The company has an authorised share capital of ₹7.55 Cr and a paid-up capital of ₹7.45 Cr. It is led by directors including Madhusudhana Reddy Bommareddy (Managing Director) and Venkatram Reddy Pulagam.

Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 39 – 8 – 19 B.S.Reddy Street Labbipet, Vijayawada, Andhra Pradesh, India – 520010.

As per the financials filed for FY 2024, the company reported a revenue of ₹70.08 Cr, a growth of 7% compared to the previous year. For the same year it recorded a net profit of ₹6.54 Cr (net margin 9.3%) and EBITDA of ₹14.59 Cr (EBITDA margin 20.8%). Revenue has grown at a compounded annual rate (CAGR) of 23% over three years and 27% over five years.

The company has about 142 employees on its provident fund (EPFO) records.

As per MCA filings, the company has open charges of ₹32.26 Cr and satisfied charges of ₹38.88 Cr on record. Court records list 7 cases involving the company, including 1 filed by the company and 6 filed against it; 3 cases are pending. The company has 2 deals on record (2 funding rounds), with disclosed funding of ₹7.2 Cr; the latest was in December 2014. Its 8 peer companies in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 4 larger and 4 smaller; the largest is S R Laboratories Private Limited with revenue of ₹72.1 Cr.

Actis Generics Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-AP-10-0009655). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website actispharma.com.

Company details

CIN U24230AP2012PTC080702
Registration Number 080702
Incorporation Date 03 May 2012
ROC Vijayawada
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-AP-10-0009655

Recognitions & Rankings of Actis Generics

MSME (Udyam registered) Ministry of MSME
Category
Medium (2024-25)
Udyam number
UDYAM-AP-10-0009655

Contact details

Actis Generics Private Limited's registered office is in Vijayawada, Andhra Pradesh. Its website is actispharma.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    39 – 8 – 19 B.S.Reddy Street Labbipet, Vijayawada, Andhra Pradesh, India – 520010
  • Industry
    Pharma, API Manufacturers

To see the full contact details of Actis Generics Private Limited, buy the company report.

Comprehensive company report
Actis Generics Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Actis Generics is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Actis Generics Private Limited, buy the company report.

Financials of Actis Generics Private Limited

FY 2024 filings available

Actis Generics Private Limited reported revenue of ₹70.08 Cr (up 7% YoY) for FY 2024.

Revenue · FY 2024
₹70.08 Cr ▲ 7%
Net profit · FY 2024
₹6.54 Cr margin 9.3%
EBITDA · FY 2024
₹14.59 Cr margin 20.8%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 7%
3 years · compounded
▲ 23%
5 years · compounded
▲ 27%
EBITDA CAGR growth
1 year
▼ 8%
3 years · compounded
▲ 2%
5 years · compounded
▲ 35%

Revenue has grown at a compounded annual rate (CAGR) of 27% over five years, including 7% growth in the latest year. EBITDA fell 8% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹14.59 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)₹6.54 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profitability
EBITDA Margin20.8%
Net Profit Margin9.3%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Actis Generics Private Limited, buy the company report.

Board of directors of Actis Generics Private Limited

Actis Generics has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Venkatram Reddy PulagamDirector03 May 201214 Years 6 MonthsCurrent
Veera Venkata Siva Kumar Reddy BommareddyDirector03 May 201214 Years 6 MonthsCurrent
Madhusudhana Reddy BommareddyManaging Director03 May 201214 Years 6 MonthsCurrent

Peer comparison

Actis Generics Private Limited is compared with the 8 companies closest to it by revenue in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
S R Laboratories Private Limited₹72.1 Cr (FY 2025)22.0%Telangana, India
Pellets Pharma Limited₹72.09 Cr (FY 2024)2.0%Hyderabad, Telangana, India
Chemcrux Enterprises Limited₹71.5 Cr (FY 2025)-10.0%Vadodara, Gujarat, India
Nico Orgo Marketing Private Limited₹70.53 Cr (FY 2024)-50.0%Kheda, Gujarat, India
Actis Generics Private Limitedthis company₹70.08 Cr (FY 2024)₹6.54 Cr9.3%7.0%142Vijayawada, Andhra Pradesh, India
Vibrant Pharmachem Private Limited₹69.73 Cr (FY 2024)-10.0%Raichur, Karnataka, India
Sunlight Active Drug Ingredients Private Limited₹69.28 Cr (FY 2025)-2.0%Hyderabad, Telangana, India
Amgis Lifescience Limited₹68.51 Cr (FY 2024)13.0%Vapi, Gujarat, India
Sanmar Speciality Chemicals Limited₹68.48 Cr (FY 2018)11.0%Chennai, Tamil Nadu, India

To see the full peer comparison of Actis Generics Private Limited, buy the company report.

Auditor

Actis Generics Private Limited is audited by BVS PRAKASH &CO for the financial year 2023.

Auditor firmFinancial yearFirm registration number
BVS PRAKASH &COFY 2023002727S

Shareholding

The shareholding of Actis Generics Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021FY 2020FY 2019
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Actis Generics Private Limited, buy the company report.

Charges & borrowings

Open charges
₹32.26 Cr
Satisfied charges
₹38.88 Cr
Breakdown by lending institutions
Others₹31.97 Cr
Hdfc Bank Limited₹0.29 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
12 Sep 2023100821960Others₹20 LakhOpen
17 Jun 2022100590455Hdfc Bank Limited₹28.53 LakhOpen
27 Jan 2022100563264Others₹1.77 CrOpen
18 Mar 2021100464062Others₹30 CrOpen
22 Feb 2019100246273Others₹14.61 CrSatisfied

To see the full charge records of Actis Generics Private Limited, buy the company report.

Total charge records: 7 View all charges

Deals & funding

Actis Generics Private Limited has 2 deals on record (2 funding rounds), with disclosed funding of ₹7.2 Cr; the latest was in December 2014.

Total deals
2
Funding rounds
2
Disclosed funding
₹7.2 Cr

Deals on record (2 of 2)

WhenDealAmountParties
Dec 2014Funding round₹4.45 CrInvestors: 4 individuals
Apr 2013Funding round₹2.75 CrInvestors: 4 individuals

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

Credit ratings & regulatory alerts

Actis Generics Private Limited was last rated by Care on 07 Mar 2022.

Rating agencyRated onRating
Care07 Mar 2022

To see the full credit ratings and regulatory alerts of Actis Generics Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Actis Generics Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

Actis Generics Private Limited has a workforce of 142 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.

Employee count
142
Active EPFO establishments
1
Employee growth
-10.7%

Headcount by financial year

Financial yearEmployees (EPFO)
FY 2026-27142
FY 2025-26
FY 2024-25
FY 2023-24
FY 2022-23
FY 2021-22
FY 2020-21
FY 2019-20
FY 2018-19
FY 2017-18
FY 2016-17

To see the full employee and EPFO history of Actis Generics Private Limited, buy the company report.

GST

Actis Generics has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
37AAKCA5168N1Z1Andhra PradeshActive01 Jul 2017

To see the full GST registrations and return filing status of Actis Generics Private Limited, buy the company report.

Recent activity

Actis Generics Private Limited has 5 board changes on record since 2012: 3 appointments and 2 cessations. The latest: Ramprasad Reddy Bommareddy ceased to be Director on 01 Feb 2025.

Charges
A charge registered on 22 Feb 2019 via Charge ID 100246273 with Others was fully satisfied on 27 Oct 2025.
Charges
A charge registered on 08 Feb 2013 via Charge ID 10415075 with Others was fully satisfied on 27 Oct 2025.
Ceased
Ramprasad Reddy Bommareddy ceased to be Director.
Ceased
Usharani Bommareddy ceased to be Director.
AGM
Actis Generics Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Actis Generics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Vijayawada.
Charges
A charge with Others amounted to Rs. 0.20 Cr with Charge ID 100821960 was registered on 12 Sep 2023.
Charges
A charge with Others of Rs. 30.00 Cr registered on 18 Mar 2021 with Charge ID 100464062 was modified on 27 Oct 2022.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.29 Cr with Charge ID 100590455 was registered on 17 Jun 2022.
Charges
A charge with Others amounted to Rs. 1.77 Cr with Charge ID 100563264 was registered on 27 Jan 2022.
Charges
A charge registered on 08 Feb 2013 via Charge ID 10415076 with Union Bank Of India was fully satisfied on 09 Apr 2021.
Charges
A charge with Others amounted to Rs. 30.00 Cr with Charge ID 100464062 was registered on 18 Mar 2021.

9 earlier events are in the company report.

Frequently asked questions

Actis Generics is an active private limited company based in Vijayawada, Andhra Pradesh, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 03 May 2012 (14+ years old) and is registered under CIN U24230AP2012PTC080702.

Actis Generics has 3 current directors:

The latest financial statements of Actis Generics on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.

The GSTIN of Actis Generics is 37AAKCA5168N1Z1, registered in Andhra Pradesh.

The CIN (Corporate Identification Number) of Actis Generics is U24230AP2012PTC080702. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Actis Generics has 7 court cases on record: 1 filed by the company and 6 filed against it. 3 are pending. Most are in the district courts.

Actis Generics was incorporated on 03 May 2012, making it 14+ years old. It is registered with the Registrar of Companies, Vijayawada.

Actis Generics has 2 deals on record (2 funding rounds), with disclosed funding of ₹7.2 Cr; the latest was in December 2014.

The peers of Actis Generics by revenue are S R Laboratories Private Limited, Pellets Pharma Limited, Chemcrux Enterprises Limited, Nico Orgo Marketing Private Limited, Vibrant Pharmachem Private Limited and 3 more, all in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

Ramprasad Reddy Bommareddy ceased to be Director on 01 Feb 2025. Usharani Bommareddy ceased to be Director on 01 Feb 2025. Madhusudhana Reddy Bommareddy was appointed as Managing Director on 03 May 2012. Actis Generics has 5 board changes on record in total.

Yes, Actis Generics is registered as a medium enterprise under Udyam registration (number: UDYAM-AP-10-0009655).